Insulin and C-Peptide Levels After Oral and Intravenous Glucose: Contribution of Enteroinsular Axis to Insulin Secretion
Abstract
Peripheral venous plasma insulin and C-peptide concentrations were measured in 10 healthy volunteers, given either 100 g glucose orally or sufficient intravenous (i.v.) glucose to produce similar glucose concentrations when measured in arterialized blood. The incremental areas under both the insulin and C-peptide curves were significantly increased after oral as compared with i.v. glucose administration by 229% and 138%, respectively. Arteriovenous plasma glucose differences were higher after oral glucose administration and were positively correlated with plasma insulin concentrations. Plasma gastric inhibitory polypeptide (GIP) and insulin concentrations were measured in seven healthy volunteers given oral glucose loads ranging from 25 to 200 g. Both the magnitude and duration of the GIP and insulin responses after oral glucose ingestion were dose dependent. These results suggest that the main cause of the increase in peripheral insulin levels after large oral carbohydrate loads is augmented insulin secretion rather than reduced hepatic extraction, indicating the possibility that an enteroinsular factor does exist, in accordance with the “incretin” concept. They also emphasize the need to document both arterial and venous glucose concentrations for the correct interpretation of experiments investigating glucose homeostasiS.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Arteriovenous differences in plasma glucose are negligible in the postabsorptive state, but substantial gradients (~15-30% at maximum) develop after glucose ingestion.
“Although arteriovenous differences in plasma glucose are negligible in the postabsorptive state, substantial gradients (~ 15-30% at maximum) develop after glucose ingestion (24, 25).”
From Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. (1987) · cites this paper as [25]
Cited by
Sorted by citations
NAUCK, M. A., HOMBERGER, E., SIEGEL, E. G., ALLEN, R. C., EATON, R. P., EBERT, R., & CREUTZFELDT, W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-492 · Cited by 874 · see citing works
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824 · see citing works
Schwartz, N. S., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112884 · Cited by 394 · see citing works
Oral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity
Breda, E., Cavaghan, M. K., Toffolo, G., Polonsky, K. S., & Cobelli, C. (2001) · Diabetes · doi:10.2337/diabetes.50.1.150 · Cited by 320 · see citing works
Gut hormones and diabetes mellitus
Creutzfeldt, W., & Nauck, M. (1992) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610080206 · Cited by 176 · see citing works
Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects
Nuttall, F. Q., & Gannon, M. C. (1991) · Diabetes Care · doi:10.2337/diacare.14.9.824 · Cited by 152 · see citing works
SIMON, C., BRANDENBERGER, G., & FOLLENIUS, M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-669 · Cited by 147 · see citing works
- Authors
- Hampton, S. M., Morgan, L. M., Tredger, J. A., Cramb, R., & Marks, V
- Affiliations
- University of Surrey (GB)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1986-05-01
- Volume
- 35
- Issue
- 5
- Pages
- 612-616
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1979251485
- Cited by
- 80
- References
- 0
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2017: 1 · 2016: 2 · 2015: 3
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin secretion, C-peptide, enteroinsular axis, incretins, glucose-dependent insulinotropic polypeptide, oral glucose tolerance, intravenous glucose, arteriovenous glucose difference, hepatic insulin extraction, glucose homeostasis
- MeSH terms
- Insulin Secretion, Administration, Oral, Adult, Animals, Blood Glucose, C-Peptide, Dogs, Dose-Response Relationship, Drug, Female, Gastric Inhibitory Polypeptide, Glucose, Humans, Hyperglycemia, Infusions, Parenteral, Insulin, Islets of Langerhans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review